WHO OKs emergency use of Japanese mpox vaccine amid surge

The World Health Organization said Tuesday it has granted emergency use of a Japanese mpox vaccine, its second approval of a product to inoculate against the infectious disease, to combat a recent outbreak mainly in Africa.The approval of the vaccine, developed by KM Biologics Co., a group firm of food and pharmaceutical company Meiji Holdings Co., follows the acceptance of a vaccine manufactured by Bavarian Nordic A/S of Denmark in September."This decision is expected to facilitate increased and timely access to vaccines in communities where mpox outbreaks are surging," the Geneva-based U.…READ FULL ARTICLE